# Effects of Simvastatin on Uterine Leiomyoma Size

> **NCT03400826** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 60 (estimated)

## Conditions studied

- Fibroid Uterus
- Fibroid Tumor
- Leiomyoma
- Fibromyoma
- Leiomyoma, Uterine

## Interventions

- **DRUG:** Simvastatin 40mg
- **DRUG:** Placebo 40 mg

## Key facts

- **NCT ID:** NCT03400826
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-08-20
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03400826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03400826, "Effects of Simvastatin on Uterine Leiomyoma Size". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03400826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*